Alzheimer’s disease and other dementias: A review

American Journal of Alzheimer’s Disease and other Dementias

Volumn 17, Issue 1, 2002, Pages 11-17

  Rogan, Shannon ^a   Lippa, Carol F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer s disease; Dementia; Dementia with lewy bodies; Frontotemporal dementia; Pick s disease

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT;

AGING; ALZHEIMER DISEASE; AROUSAL; BEHAVIOR; CAREGIVER; CLINICAL FEATURE; COGNITIVE DEFECT; CORTICOBASAL DEGENERATION; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSE LEWY BODY DISEASE; DISABILITY; FAMILY; FRONTOTEMPORAL DEMENTIA; HUMAN; MENTAL CAPACITY; MORBIDITY; MULTIINFARCT DEMENTIA; PATHOGENESIS; PHYSICAL EXAMINATION; POPULATION; PROGRESSIVE SUPRANUCLEAR PALSY; PSYCHOTHERAPY; REVIEW;

EID: 0036157135     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/153331750201700106     Document Type: Review

References (28)

1. Diagnosis and treatment of Alzheimer disease and related disorders: Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer’s Association, and the American Geriatrics Society
2. Mini-mental state": A practical method for grading the cognitive state of patients for the clinician
3. Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease
4. Alzheimer’s disease: Genotypes, phenotypes, and treatments
5. Clinical diagnosis of Alzheimer disease: Report of the NINCDS-ADRDA work group under the auspices of Health and Human Services task force on Alzheimer’s disease
6. Familial Alzheimer’s disease Genetic influences on the disease process
7. Apolipoprotein E epsilon-4 allele and the lifetime risk of Alzheimer’s disease: What physicians know, and what they should know
8. The play project Use of stimulus objects with demented patients
9. Positive emotions in early life and longevity: Findings from the nun study
10. New drug treatments for Alzheimer disease
11. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease: The Alzheimer’s Disease Cooperative Study
12. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
13. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
14. Dementia with Lewy bodies: Review of a common subtype of dementia
15. The apolipoprotein E allele epsilon-4 is over represented in patients with the Lewy body variant of Alzheimer’s disease
16. Dementia with Lewy bodies Choline acetyltransferase parallels nucleus basalis pathology
17. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer’s disease
18. Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy
19. Alpha-synuclein in familial Alzheimer’s disease: Epitope mapping parallels DLB and Parkinson’s disease
20. Differences between Pick disease and Alzheimer disease in clinical appearance and rate of cognitive decline
21. Clinical and neuropathological criteria for frontotemporal dementia
22. Prevalence of progressive supranuclear palsy and multiple system atrophy: A cross-sectional study
23. Clinical and genetic aspects of progressive supranuclear palsy
24. Mutation in the tau exon 10 splice site region in familial frontotemporal dementia
25. Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study
26. Neuropsychological follow up in patients with Parkinson’s disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy
27. Neuropsychological pattern of striatonigral degeneration: Comparison with Parkinson’s disease and progressive supranuclear palsy
28. Practice guideline for the treatment of patients with Alzheimer’s disease and other dementias of late life